Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation
This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ta256
6 Related NICE guidance
Dabigatran etexilate for the prevention of stroke or systemic embolism in atrial fibrillation. NICE technology appraisal guidance 249 (2012).
Thoracoscopic exclusion of the left atrial (with or without surgical ablation) for non-valvular atrial fibrillation for the prevention of thromboembolism. NICE interventional procedure guidance 400 (2011).
Dronedarone for the treatment of non-permanent atrial fibrillation. NICE technology appraisal guidance 197 (2010).
Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism. NICE interventional procedure guidance 349 (2010).
The management of atrial fibrillation. NICE clinical guideline 36 (2006).